Ikuti
Rusha Pal
Rusha Pal
Brigham and Women's Hospital, Harvard Medical School
Email yang diverifikasi di bwh.harvard.edu
Judul
Dikutip oleh
Dikutip oleh
Tahun
Nanosecond electric pulses rapidly enhance the inactivation of Gram-negative bacteria using Gram-positive antibiotics
RA Vadlamani, A Dhanabal, DA Detwiler, R Pal, J McCarthy, MN Seleem, ...
Applied microbiology and biotechnology 104, 2217-2227, 2020
262020
Probiotics: insights and new opportunities for Clostridioides difficile intervention
R Pal, AIM Athamneh, R Deshpande, JAR Ramirez, KT Adu, ...
Critical reviews in microbiology 49 (3), 414-434, 2023
222023
Screening of Natural Products and Approved Oncology Drug Libraries for Activity against Clostridioides difficile
R Pal, MN Seleem
Scientific Reports 10 (1), 5966, 2020
192020
β, γ-Diaryl α-methylene-γ-butyrolactones as potent antibacterials against methicillin-resistant Staphylococcus aureus
HJ Hamann, NS Abutaleb, R Pal, MN Seleem, PV Ramachandran
Bioorganic Chemistry 104, 104183, 2020
152020
High-throughput screening identifies a novel natural product-inspired scaffold capable of inhibiting Clostridioides difficile in vitro
R Pal, M Dai, MN Seleem
Scientific reports 11 (1), 10913, 2021
122021
Discovery of a novel natural product inhibitor of Clostridioides difficile with potent activity in vitro and in vivo
R Pal, MN Seleem
Plos one 17 (8), e0267859, 2022
92022
Discovery of 1, 2-diaryl-3-oxopyrazolidin-4-carboxamides as a new class of MurA enzyme inhibitors and characterization of their antibacterial activity
RA Wagdy, NS Abutaleb, RK Fathalla, Y Elgammal, S Weck, R Pal, ...
European Journal of Medicinal Chemistry 261, 115789, 2023
42023
Antisense inhibition of RNA polymerase α subunit of Clostridioides difficile
R Pal, MN Seleem
Microbiology Spectrum 11 (5), e01755-23, 2023
42023
Identification of N-(5-nitrothiazol-2-yl)-3-oxopyrazolidine-4-carboxamide derivative as a potent inhibitor of Clostridioides difficile
R Wagdy, N Abutaleb, Y El-Gammal, R Pal, A Abadi, M Seleem, M Engel, ...
MDPI, 2023
2023
Investigating novel treatment approaches to combat Clostridioides difficile
R Pal
Virginia Tech, 2023
2023
Identification of N-(5-Nitrothiazol-2-yl)-3-oxopyrazolidine-4-carboxamide Derivative as a Potent Inhibitor of Clostridioides difficile. 2023, 14, x
RA Wagdy, NS Abutaleb, Y Elgammal, R Pal, AH Abadi, MN Seleem, ...
2023
Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.
Artikel 1–11